| Genomic variations and chromosomal abnormalities | Lifetime | 64 | CN 2 | 99.22 |
| Cancer-related molecular mechanisms research | Lifetime | 252 | CN 114 | 99.00 |
| Ferroptosis and cancer prognosis | Lifetime | 84 | CN 29 | 98.60 |
| Cancer Cells and Metastasis | Lifetime | 154 | CN 5 | 99.20 |
| RNA modifications and cancer | Lifetime | 377 | CN 37 | 99.16 |
| Cancer-related gene regulation | Lifetime | 144 | CN 10 | 98.99 |
| Cancer Genomics and Diagnostics | Lifetime | 533 | CN 8 | 99.00 |
| Epigenetics and DNA Methylation | Lifetime | 746 | CN 60 | 98.29 |
| Molecular Biology Techniques and Applications | Lifetime | 315 | CN 14 | 97.54 |
| MicroRNA in disease regulation | Lifetime | 772 | CN 289 | 97.75 |
| Genetic factors in colorectal cancer | Lifetime | 603 | CN 13 | 97.95 |
| Immune cells in cancer | Lifetime | 552 | CN 67 | 97.14 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 675 | CN 57 | 97.49 |
| Cancer-related Molecular Pathways | Lifetime | 912 | CN 45 | 97.10 |
| Cancer Mechanisms and Therapy | Lifetime | 868 | CN 165 | 92.47 |
| Polyamine Metabolism and Applications | Lifetime | 795 | CN 25 | 93.29 |
| FOXO transcription factor regulation | Lifetime | 193 | CN 27 | 91.24 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 892 | CN 59 | 88.09 |
| Clusterin in disease pathology | Lifetime | 334 | CN 26 | 70.76 |
| Cancer Cells and Metastasis | 2021-2025 | 15 | CN 3 | 98.51 |
| Immune cells in cancer | 2021-2025 | 93 | CN 54 | 97.68 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 770 | CN 164 | 97.06 |
| Cancer Genomics and Diagnostics | 2021-2025 | 655 | CN 47 | 95.99 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 300 | CN 126 | 93.14 |
| RNA modifications and cancer | 2021-2025 | 978 | CN 669 | 93.52 |
| Epigenetics and DNA Methylation | 2021-2025 | 796 | CN 296 | 91.28 |
| CRISPR and Genetic Engineering | 2021-2025 | 761 | CN 295 | 89.88 |
| Cancer-related gene regulation | 2021-2025 | 983 | CN 668 | 76.13 |
| Cancer Mechanisms and Therapy | 2021-2025 | 754 | CN 330 | 74.82 |
| Medical Image Segmentation Techniques | 2021-2025 | 741 | CN 416 | 74.88 |
| Hippo pathway signaling and YAP/TAZ | 2021-2025 | 533 | CN 233 | 65.30 |
